<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>İçeriğe göre en uygun 5 etiket: **Oral squamous cell carcinoma &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/icerige-gore-en-uygun-5-etiket-oral-squamous-cell-carcinoma/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 10:28:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>İçeriğe göre en uygun 5 etiket: **Oral squamous cell carcinoma &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Astragalus Polysaccharide Boosts STM2457 in OSCC Therapy</title>
		<link>https://bioengineer.org/astragalus-polysaccharide-boosts-stm2457-in-oscc-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 10:27:47 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Astragalus polysaccharide]]></category>
		<category><![CDATA[Based on the content]]></category>
		<category><![CDATA[Combinatorial Cancer Treatment]]></category>
		<category><![CDATA[Combinatorial therapy]]></category>
		<category><![CDATA[Epitranscriptomics** * **Oral squamous cell carcinoma:** Makalenin temel odak noktası (OSCC). * **m6A methylation:** Ana hedef mekanizma ve STM2457'in etki alanı. * **Combinatorial]]></category>
		<category><![CDATA[here are 5 appropriate tags focusing on the key concepts: **Epitranscriptomic Therapy]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Oral squamous cell carcinoma]]></category>
		<category><![CDATA[m6A methylation]]></category>
		<category><![CDATA[m6A Methylation Inhibition]]></category>
		<category><![CDATA[Oral squamous cell carcinoma]]></category>
		<guid isPermaLink="false">https://bioengineer.org/astragalus-polysaccharide-boosts-stm2457-in-oscc-therapy/</guid>

					<description><![CDATA[In a groundbreaking advance poised to reshape the therapeutic landscape of oral squamous cell carcinoma (OSCC), recent research spearheaded by Wang X. has illuminated a compelling synergy between astragalus polysaccharide (APS) and STM2457, a novel m6A RNA methylation inhibitor. As OSCC remains a formidable oncological challenge due to its aggressive nature and often limited treatment [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318845</post-id>	</item>
	</channel>
</rss>
